Skip to content
★ Sign in to follow
SW

Susan Wang

Executive
Total declarations
66
Companies
6
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€4.7M

Latest filing published 26 Jan 2016 for Premier, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
16
Signal history

No signal scores available.

Susan Wang: trading record in brief

Susan Wang discloses dealings in 6 companies, chiefly Altera Corp, Nektar Therapeutics and Avanex Corp. The record holds 66 filings, for trades running from 18 September 2006 to 25 January 2016.

On the market, this insider has only sold: 16 sales, €4.7M in total. Besides market trades, the filings include 19 share grants and 30 option exercises.

The newest entry dates from 26 January 2016: a share grant, in Premier, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Susan Wang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations61 total
  • ◆
    DirectorExecutivesPremier, Inc.
    0SEC
    3,134 sharesClass A Common StockSEC:0001209191-16-093608:0
  • ◇
    DirectorExecutivesNektar Therapeutics
    369,600 USD0SEC
    40,000 shares@ US$9.24Common StockSEC:0001209191-15-081660:8
  • ▼
    DirectorExecutivesNektar Therapeutics
    600,800 USD0SEC
    40,000 shares@ US$15.02Common StockSEC:0001209191-15-081660:9
  • ◇
    DirectorExecutivesNektar Therapeutics
    125,550 USD0SEC
    15,000 shares@ US$8.37Common StockSEC:0001209191-15-081660:0
  • ▼
    DirectorExecutivesNektar Therapeutics
    225,000 USD0SEC
    15,000 shares@ US$15.00Common StockSEC:0001209191-15-081660:1
  • ◇
    DirectorExecutivesNektar Therapeutics
    27,612 USD0SEC
    5,372 shares@ US$5.14Common StockSEC:0001209191-15-081660:2
  • ▼
    DirectorExecutivesNektar Therapeutics
    80,580 USD0SEC
    5,372 shares@ US$15.00Common StockSEC:0001209191-15-081660:3
  • ◇
    DirectorExecutivesNektar Therapeutics
    77,758 USD0SEC
    15,128 shares@ US$5.14Common StockSEC:0001209191-15-081660:4
  • ▼
    DirectorExecutivesNektar Therapeutics
    227,223 USD0SEC
    15,128 shares@ US$15.02Common StockSEC:0001209191-15-081660:5
  • ◇
    DirectorExecutivesNektar Therapeutics
    48,830 USD0SEC
    9,500 shares@ US$5.14Common StockSEC:0001209191-15-081660:6
  • ▼
    DirectorExecutivesNektar Therapeutics
    142,690 USD0SEC
    9,500 shares@ US$15.02Common StockSEC:0001209191-15-081660:7
  • ◇
    DirectorExecutivesNektar Therapeutics
    132,150 USD0SEC
    15,000 shares@ US$8.81Common StockSEC:0001209191-15-057918:0
  • ▼
    DirectorExecutivesNektar Therapeutics
    190,500 USD0SEC
    15,000 shares@ US$12.70Common StockSEC:0001209191-15-057918:1
  • ◇
    DirectorExecutivesNektar Therapeutics
    77,250 USD0SEC
    15,000 shares@ US$5.15Common StockSEC:0001209191-15-057918:2
  • ◇
    DirectorExecutivesCirrus Logic, Inc.
    347,338 USD0SEC
    22,687 shares@ US$15.31Common StockSEC:0001273902-15-000016:0
  • ▼
    DirectorExecutivesCirrus Logic, Inc.
    670,174 USD0SEC
    22,687 shares@ US$29.54Common StockSEC:0001273902-15-000016:1
  • ▼
    DirectorExecutivesCirrus Logic, Inc.
    574,600 USD0SEC
    19,445 shares@ US$29.55Common StockSEC:0001273902-15-000016:2
  • ◆
    DirectorExecutivesPremier, Inc.
    0SEC
    3,049 shares0Class A Common StockSEC:0001179110-15-001381:0
  • ◆
    DirectorExecutivesCirrus Logic, Inc.
    0SEC
    6,462 shares0Common StockSEC:0001273902-14-000024:0
  • ◆
    DirectorExecutivesPremier, Inc.
    0SEC
    3,704 shares0Class A Common StockSEC:0001179110-13-014706:0
  • ◆
    DirectorExecutivesCirrus Logic, Inc.
    0SEC
    7,672 shares0Common StockSEC:0001273902-13-000037:0
  • ◇
    DirectorExecutivesAltera Corp
    128,501 USD0SEC
    5,833 shares@ US$22.03Common StockSEC:0001406390-13-000057:0
  • ▼
    DirectorExecutivesAltera Corp
    196,864 USD0SEC
    5,833 shares@ US$33.75Common StockSEC:0001406390-13-000057:1
  • ◇
    DirectorExecutivesAltera Corp
    207,300 USD0SEC
    10,000 shares@ US$20.73Common StockSEC:0001406390-13-000057:2
  • ▼
    DirectorExecutivesAltera Corp
    337,500 USD0SEC
    10,000 shares@ US$33.75Common StockSEC:0001406390-13-000057:3

25 of 61 declarations